Beam Therapeutics Inc. (BEAM)
NASDAQ·Healthcare·Biotechnology
$26.16
-1.15%
Mkt Cap $2.81B
Analyst Ratings
Buy
12
Hold
0
Sell
0
Price Target (19 analysts)
$59.50
Range $39.00 – $80.00
Implied Upside
+127.4%
Consensus $59.50 vs current $26.16
NASDAQ·Healthcare·Biotechnology
$26.16
-1.15%
Mkt Cap $2.81B
Buy
12
Hold
0
Sell
0
Price Target (19 analysts)
$59.50
Range $39.00 – $80.00
+127.4%
Consensus $59.50 vs current $26.16